debrisoquin has been researched along with desmethylselegiline in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anttila, M; Bertilsson, L; Dahl, ML; Karnani, H; Nyman, L; Pelkonen, O; Scheinin, H; Taavitsainen, P | 1 |
1 trial(s) available for debrisoquin and desmethylselegiline
Article | Year |
---|---|
CYP2D6 polymorphism is not crucial for the disposition of selegiline.
Topics: Adrenergic Agents; Adult; Amphetamines; Area Under Curve; Cytochrome P-450 CYP2D6; Debrisoquin; Female; Humans; In Vitro Techniques; Male; Methamphetamine; Microsomes, Liver; Monoamine Oxidase Inhibitors; Polymorphism, Genetic; Reference Values; Selegiline | 1998 |